Granulomatous hepatitis associated with etanercept therapy

Journal of Rheumatology

Volumn 35, Issue 2, 2008, Pages 349-351

  Farah, Myriam ^a,b   Al Rashidi, Abdulrahman ^a,b   Owen, David A ^a,b   Yoshida, Eric M ^a,c   Reid, Graham D ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Laboratory Medicine

^c Department of Gastroenterology ^*  (Canada)

Author keywords

Etanercept; Granulomatous; Hepatitis; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; GOLD; LIVER ENZYME; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

ADOLESCENT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GRANULOMATOUS HEPATITIS; HUMAN; LIVER BIOPSY; LIVER DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SARCOIDOSIS; TREATMENT OUTCOME;

ADOLESCENT; ARTHRITIS, RHEUMATOID; CHOLAGOGUES AND CHOLERETICS; FEMALE; HEPATITIS, TOXIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; URSODEOXYCHOLIC ACID;

EID: 39549084950     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tomasini C, Pippione M. Interstitial granulomatous dermatitis with plaques. J Am Acad Dermatol 2002;46:892-9.
2. Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 2006;142:198-202.
3. Yousem SA, Dacic S. Pulmonary lymphohistiocytic reactions temporarily related to etanercept therapy. Mod Pathol 2005; 18:651-5.
4. Peno-Green L, Lluberas G, Kingsley T, Brantley S. Lung injury linked to etanercept therapy. Chest 2002;122:1858-60.
5. Phillips K, Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 2006;53:618-20.
6. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R, Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 2007;26:1969-71.
7. Kudrin A, Chilvers ER, Ginawi A, et al. Sarcoid-like granulomatous disease following etanercept treatment for RA, J Rheumatol 2007;34:648-9.
8. Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC, Fernandez-Llaca H, Rodriguez-Valverde V. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2006;55:817-20.
9. Menghini VV, Arora AS. Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 2001;76:84-6.
10. Tobon GJ, Canas C, Jaller JJ, Restrepo JC, Anaya JM. Serious liver disease induced by infliximab. Clin Rheumatol 2007;26:578-81.